Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 12 years of age or older, of any gender
- You have signed the official consent form agreeing to take part in the study
- You have been diagnosed by a doctor with non-segmental vitiligo (a type of vitiligo that affects both sides of the body in a scattered pattern)
- The white patches from your vitiligo cover less than 10% of your total body surface area
- You are willing to stop all other vitiligo treatments from the start of the study until your final check-up visit
- If you can become pregnant, you must agree not to try to get pregnant or donate eggs from the start of the study until 4 weeks after your last dose, and you must use a reliable form of physical contraception (such as condoms, a diaphragm, an IUD, or surgical sterilisation done at least 6 months before the study)
- If you can father a child, you must agree not to try to conceive or donate sperm during the same period, and you must also use a reliable form of physical contraception
Who may not be able to join:
- You have a known allergy to ruxolitinib cream (the treatment being studied)
- You are currently pregnant or breastfeeding
- Your doctor feels that, for any reason, it would not be appropriate for you to take part in this study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jinzhu Guo, MD, Peking University Third Hospital
Phone: 008615611963350
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the proportion of achieving T-VASI50 (50% improvement of total vitiligo area scoring index T-VASI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.